The top global medtech industry dynamics identified by the G-MedTech Research team over the past week, briefly presented in multiple languages.
Cook Medical sells its remaining Otolaryngology, Head & Neck Surgery (OHNS) product lines, excluding employees, facilities and manufacturing equipment, to C2Dx, a portfolio company of Shore Capital Partners.
SS Innovations sells its SSi Mantra Surgical Robotic System in India through a distribution partnership with Medikabazaar, a leading medical equipment supplier in India with more than 40 domestic and global centers.
Abbott receives the US FDA approval for the Liberta RC™ DBS System, the world’s smallest rechargeable deep brain stimulation device with remote programming, to treat people with movement disorders.
Element Science receives the European Union’s CE mark certification and Great Britain’s UK Conformity Assessed (UKCA) marking for its novel Patch Wearable Cardioverter Defibrillator (P-WCD), which was designed to address limitations with traditional garment-based WCDs.
AngioDynamics receives the US FDA clearance of the Auryon XL Catheter, a 225-cm radial access catheter, for use with the Auryon Atherectomy System in the treatment of Peripheral Arterial Disease (PAD).
Switzerland-based icotec ag raises $30 million from MVM Partners to commercialize its BlackArmor® Carbon/PEEK products which may offer significant clinical advantages over traditional metal implants in the context of spine oncology.
China-based DPM Company closes over RMB 200 million ($28 million) Series C financing led by DHLT Ventures, and followed by Hifinity Investment and Qunqi Partners, for the development of molecular imaging technologies.
Motif Neurotech closes an oversubscribed $18.75 million Series A financing led by Arboretum Ventures to advance the development of its DOT Microstimulator, a miniature brain pacemaker designed to precisely stimulate the brain to restore healthy circuit activity to treat mental health disorders.